Navigation Links
Promising Therapy for Prostate Cancer
Date:6/22/2009

Experimental drug beat back inoperable cancer in two patients, study claims

MONDAY, June 22 (HealthDay News) -- An experimental drug therapy appears to have helped destroy allegedly inoperable prostate cancer in two patients in a clinical trial.

Use of the immunotherapeutic agent MDX-010, or ipilimumab, in combination with standard hormone and radiation treatments helped eliminate the aggressive tumors, which had already spread into the patients' abdominal areas, according to a report from Mayo Clinic researchers that appears in Discovery's Edge, the Mayo Clinic's online research magazine. Both patients are now considered cancer-free.

"The tumors had shrunk dramatically," co-investigator Dr. Michael Blute, a Mayo urologist and surgeon who operated on both patients, said in a Mayo Clinic news release. "I had never seen anything like this before. I had a hard time finding the cancer. At one point, the pathologist [who was working during surgery] asked if we were sending him samples from the same patient."

Ipilimumab is an antibody that appears to greatly magnify the cancer-killing action of androgen ablation, a hormone therapy that helps shrink prostate cancer by eliminating testosterone from the body. Following the additional treatment, the patients showed steady decreases in their prostate-specific antigen (PSA) counts, a test used to detect prostate cancer, and were deemed eligible for surgery. After surgery, one patient underwent additional radiation therapy.

"This is one of the Holy Grails of prostate cancer research," clinical trial leader Dr. Eugene Kwon, a Mayo Clinic urologist, said of the antibody therapy in the same news release.

The team plans more research into how ipilimumab works and how to optimize its use.

More information

The American Cancer Society has more about '/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

1

GOOD

Page: 1 2

Related medicine news :

1. Promising drug combination may help those with ocular melanoma that has spread
2. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
3. Molecule Promising Against Huntingtons Disease
4. Computerized training of working memory is a promising therapeutic strategy in ADHD
5. Baicalin might be a promising therapeutic tool for severe acute pancreatitis
6. Initial Evaluation of New Nucleus Removal Device Provides Promising Results
7. Promising new TB drug given special status by US and European regulators
8. New Drug Promising Against Tough-to-Treat Kidney Cancer
9. Einstein scientists treat cancer as an infectious disease -- with promising results
10. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
11. Protalix BioTherapeutics prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Promising Therapy for Prostate Cancer
Promising Therapy for Prostate Cancer
(Date:5/23/2012)... The number of viral infections during infancy is ... a new study from researchers in the Netherlands. While ... in childhood, this association was due in part to ... infancy, particularly rhinovirus, are thought to be a risk ... whether this association is due to the viruses themselves ...
(Date:5/22/2012)... (MRI) provides an indication of a breast tumor,s ... through clinical examination, according to a new study ... , Women with breast cancer often undergo ... women who receive this treatment, known as neoadjuvant ... than those receiving chemotherapy after surgery. , Clinicians ...
(Date:5/22/2012)... Ky. (May 17, 2012) The University of Kentucky ... to study a deadly blood and bone marrow disease ... million grant from the Edward P. Evans Foundation, along ... of myelodysplastic syndrome (MDS). , The Evans Foundation grant ... three labs at UK, one at Cincinnati Children,s Hospital, ...
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 ... no longer recommends that men routinely undergo prostate ... should ask their doctors for the exam if ... Urologists and cancer experts dismissed the idea that ... the PSA test will set a man,s personal ...
(Date:5/22/2012)... Pushed to the brink of survival, the hyper-driven ... system that has helped organisms cope with internal stresses ... integral part of this system, heat shock protein 90 ... the genetic changes and profound disturbances in normal biology ... that inhibiting HSP90 just might render breast cancer cells ...
Breaking Medicine News(10 mins):Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 3Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 2Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 3Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 2Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 3
... 5 proteins could detect disease sooner, when it,s more treatable ... to early development of pancreatic cancer have been identified by ... in efforts to develop a blood test to detect this ... are highest. , "Our team identified, for the first ...
... France, Friday 13 June 2008: The TRAF1/C5 locus on ... in multiple autoimmune diseases including type 1 diabetes and ... today at EULAR 2008, the Annual Congress of the ... TRAF1 (Tumour Necrosis Factor-receptor associated factor 1) and C5 ...
... France, Friday 13 June 2008: Tocilizumab plus methotrexate ... in patients with moderate to severe rheumatoid arthritis ... necrosis factor (anti-TNF) therapy, according to a new ... Congress of the European League Against Rheumatism in ...
... HARRISBURG, Pa., June 13 Governor Edward G. ... which will protect,Pennsylvanians from the deadly health effects of ... restaurants,workplaces and a portion of casino floors., "All ... who refused to quit working until we had joined ...
... One in 8 NYC residents near scene affected years later, ... News) -- Two to three years after the World Trade ... near the site had signs of post-traumatic stress disorder (PTSD), ... This rate, 12.6 percent, among Lower Manhattan residents is three ...
... Paris, France, Friday 13 June 2008: A new DNA ... patients with rheumatoid arthritis (RA), as presented today at ... Against Rheumatism in Paris, France. The chip (called the ... to assist physicians in anticipating likely disease progression and ...
Other Medicine News:Health News:Pancreatic Cancer Biomarkers Found 2Health News:Specific location of the TRAF1/C5 gene associated with multiple autoimmune diseases 2Health News:30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho 2Health News:Governor Rendell Signs Bill Restricting Smoking in Most Public Places in Pennsylvania 2Health News:Governor Rendell Signs Bill Restricting Smoking in Most Public Places in Pennsylvania 3Health News:PTSD High Among Witnesses to 9/11 2Health News:Novel DNA microarray chip predicts functional impairment and remission in rheumatoid arthritis 2
(Date:5/23/2012)... 2012 According to Cold ... reported temperature excursions in 6% or more of ... pharmaceutical products can not only result in product ... Cold Chain IQ presents a new report examining ... and commercial products and leading strategies that the ...
(Date:5/22/2012)... 2012  Prodigy Generics, a division of Prodigy ... Irinotecan is the generic equivalent of the branded ... with eVenus Pharmaceutical Laboratories to develop a portfolio ... several ANDAs being developed through the partnership that ... the U.S. injectable market, which has experienced record ...
(Date:5/22/2012)... SAN DIEGO, May 22, 2012  Prometheus Laboratories ... today the thirteen abstracts relating to its proprietary ... 2012. The abstracts (see full ... helping healthcare providers personalize patient care with the ... Topics span across a wide spectrum of scientific ...
Breaking Medicine Technology:New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments 2New Data Support Role of Prometheus Laboratories' Novel Assay in Optimizing IBD Treatment Management 2New Data Support Role of Prometheus Laboratories' Novel Assay in Optimizing IBD Treatment Management 3New Data Support Role of Prometheus Laboratories' Novel Assay in Optimizing IBD Treatment Management 4New Data Support Role of Prometheus Laboratories' Novel Assay in Optimizing IBD Treatment Management 5Founders of the Sebastian Ferrero Foundation Join HSH Prince Albert II of Monaco in Support of the New Art of the Olympians Museum 64103 1Founders of the Sebastian Ferrero Foundation Join HSH Prince Albert II of Monaco in Support of the New Art of the Olympians Museum 64103 2Founders of the Sebastian Ferrero Foundation Join HSH Prince Albert II of Monaco in Support of the New Art of the Olympians Museum 64103 3Founders of the Sebastian Ferrero Foundation Join HSH Prince Albert II of Monaco in Support of the New Art of the Olympians Museum 64103 4Rh Negative Blood Donors Needed Now 64100 1Rh Negative Blood Donors Needed Now 64100 2Rh Negative Blood Donors Needed Now 64100 3deCODE Receives Nasdaq Deficiency Notice 64097 1deCODE Receives Nasdaq Deficiency Notice 64097 2deCODE Receives Nasdaq Deficiency Notice 64097 3
... Alliance, an,organization comprised of 12 of the nation,s top ... power over cancer by donating $1 to,cancer research efforts ... dubbed the "Infinite Power of One(TM)" has two key ... own hands by,joining together to exercise their collective power ...
... of asenapine in the treatment of ... schizophrenia and bipolar I disorder, WASHINGTON, ... that an overview of asenapine clinical trials,from the Olympia program ... Association in Washington, D.C., May 3-8. Data from,the studies, involving ...
Other Medicine Technology:World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: